NASDAQ · Financial Statements
Opus Genetics, Inc. (IRD) Financial Statements
$4.45
NASDAQ: IRD
Market Cap $367.42M
Overview Financials Dividend Opus Genetics, Inc. most recently reported annual revenue of $14.0M, net profit of $-50.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $1.0M $40.0M $19.0M $11.0M $14.0M Operating Profit $-23.0M $18.0M $-11.0M $-62.0M $-39.0M Net Profit $-57.0M $18.0M $-10.0M $-58.0M $-50.0M EPS $-3.82 $0.87 $-0.46 $-2.15 $-0.80 Op Margin -3854.8% 45.7% -55.5% -564.7% -271.9%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $26.0M $49.0M $54.0M $37.0M $50.0M Total Liabilities $4.0M $3.0M $4.0M $30.0M $35.0M Cash $25.0M $43.0M $51.0M $30.0M $45.0M Borrowings $1.0M $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-19.0M $14.0M $-1.0M $-26.0M $-35.0M Investing Cash Flow $0 $0 $0 $1.0M $0 Financing Cash Flow $-1.0M $0 $0 $0 $0 Net Cash Flow $8.0M $18.0M $8.0M $-20.0M $15.0M Free Cash Flow $-19.0M $14.0M $-1.0M $-26.0M $-35.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.08 EV / EBITDA -2.99 FCF Yield -11.07% Quick Ratio 12.19 Interest Coverage -19.11 Return 1Y 143.33% Return 3Y -25.70% Return 5Y -10.33%
Screens featuring this stock